Phase I-II-III studies of Cisplatin and Combretastatin (CA4P) in recurrent or advanced cervical cancer
Phase of Trial: Phase III
Latest Information Update: 02 Nov 2012
At a glance
- Drugs Cisplatin (Primary) ; Fosbretabulin (Primary)
- Indications Cervical cancer
- Focus Adverse reactions; Therapeutic Use
- 02 Nov 2012 Additional lead trial centre identified as reported by European Clinical Trials Database record.
- 02 Nov 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2004-001356-37).
- 09 Dec 2005 New trial record.